Problems in Predicting Drug Effects across Species Lines
- 1 September 1973
- journal article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 1 (6), 489-503
- https://doi.org/10.1177/030006057300100601
Abstract
During the course of drug development, there are many instances where extrapolation of data from animals to man is difficult because the toxicologic and metabolic responses induced by drugs may be significantly different between the laboratory species. In cases where the drug in question has a potentially major therapeutic use in man, it is suggested that the data be evaluated on the basis of a pragmatic benefit-to-risk ratio, rather than zero-toxicity. In this way, we may provide drug therapy for those patients for whom adequate treatment does not exist, as well as protect those individuals who may be exposed to some hazard from the use of medicines.Keywords
This publication has 32 references indexed in Scilit:
- Pharmacokinetics of Highly Ionized Drugs II: Methylene Blue—Absorption, Metabolism, and Excretion in Man and Dog after Oral AdministrationJournal of Pharmaceutical Sciences, 1972
- Species differences in the metabolism of a tricyclic psychotropic agent, SQ 11,290-14CToxicology and Applied Pharmacology, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- The Use of Insulin Dynamics in the Evaluation of Streptozotocin Therapy of Malignant Insulinomas1Journal of Clinical Endocrinology & Metabolism, 1971
- The action of ranatensin, a new polypeptide from amphibian skin, on the blood pressure of experimental animalsBritish Journal of Pharmacology, 1970
- Treatment of Essential Hypertension with a New Vasodilator in Combination with Beta-Adrenergic BlockadeNew England Journal of Medicine, 1970
- Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis FungoidesAnnals of Internal Medicine, 1966
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965
- Acute Pericarditis Produced by Psicofuranine, a Nucleoside AnalogueNew England Journal of Medicine, 1961
- CLINICAL EXPERIENCE WITH ACTINOMYCIN CAnnals of the New York Academy of Sciences, 1960